Sen. Grassley Issues Statement at Hearing on Foreign Drug Manufacturing Inspection Oversight
June 03, 2020
June 03, 2020
WASHINGTON, June 3 -- Sen. Chuck Grassley, R-Iowa, chairman of the Senate Finance Committee, issued the following opening statement on June 2 at a hearing entitled "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process":
I'd like to welcome everyone to the Finance Committee's oversight hearing on the Food and Drug Administration's (FDA) foreign drug manufacturing inspection process.
This committee has an obligation to ensure . . .
I'd like to welcome everyone to the Finance Committee's oversight hearing on the Food and Drug Administration's (FDA) foreign drug manufacturing inspection process.
This committee has an obligation to ensure . . .